Office of the Director; Office of Dietary Supplements: Notice of Opportunity for Public Comment and Public Meeting, 17103-17105 [05-6606]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 63 / Monday, April 4, 2005 / Notices
interpretation or other reasonable
accommodation, in order to attend are
asked to notify the NTP at least 7
business days in advance of the
meeting.
ADDRESSES: The meeting will be held in
the Rodbell Auditorium, Rall Building
at the National Institute of
Environmental Health Sciences, 111
T.W. Alexander Drive, Research
Triangle Park, NC 27709.
FOR FURTHER INFORMATION CONTACT:
Public comments, data submission and
any other correspondence should be
submitted to Dr. Angela King-Herbert
(NIEHS, P.O. Box 12233, MD B3–06,
Research Triangle Park, NC 27709;
telephone: 919–541–3464, fax 919–541–
7666; or e-mail:
kingher1@niehs.nih.gov).
SUPPLEMENTARY INFORMATION:
Background on the NTP Vision and
Roadmap to Achieve the Vision
The NTP was established in 1978 to
coordinate toxicological testing
programs within the Department of
Health and Human Services, develop
and validate improved testing methods,
develop approaches and generate data to
strengthen scientific knowledge about
potentially hazardous substances and
communicate with stakeholders. In its
more than 25 years of existence, NTP
has become a world leader in providing
scientific information that improves our
nation’s ability to evaluate potential
human health effects from chemical and
physical exposures. The NTP maintains
a number of complex, interrelated
research and testing programs that
provide unique and critical information
needed by health regulatory and
research agencies to protect public
health.
The last decade of the 20th century
and the turn of the 21st century have
produced dramatic technological
advances in molecular biology and
computer science. The NTP is ready to
evaluate its key activities and, in a
focused and concerted effort, determine
how best to incorporate these new
scientific technologies into its research
and testing strategies and broaden
scientific knowledge on the linkage
between mechanism and disease. In
August 2003, the NTP defined its vision
for the 21st century and undertook a
yearlong process to refine that vision
and develop a roadmap for its
implementation. The NTP Vision is to
support the evolution of toxicology from
a predominately observational science
at the level of disease-specific models to
a predominately predictive science
focused upon a broad inclusion of
target-specific, mechanism-based,
VerDate jul<14>2003
15:19 Apr 01, 2005
Jkt 205001
biological observations. The NTP
roadmap for implementation of the
vision will strategically position the
program at the forefront for providing
scientific data and the interpretation of
those data for public health decisionmaking. The NTP Roadmap was
developed with input from numerous
groups including its federal partners, its
advisory committees, and the public. In
carrying out the NTP Roadmap, the
program plans to formally review the
designs of NTP assays to determine
whether protocol changes are needed.
Additional information about the NTP
Vision and Roadmap is available on its
Web site (https://ntp.niehs.nih.gov/ntp
select ‘‘NTP Vision and Roadmap’’).
The NTP periodically conducts
reviews of animal models used in the
NTP cancer bioassay including recent
evaluations on the use of fish and
transgenic mouse models as alternative
approaches (Board of Scientific
Counselors, 2004; NTP Board of
Scientific Counselors Technical Reports
Review Subcommittee, 2003; Scientific
Advisory Committee on Alternative
Toxicological Methods, 2004). However,
the last formal review of the NTP rodent
bioassay occurred in August 1984
(Report of the Ad Hoc Panel on
Chemical Carcinogenesis Testing and
Evaluation of the NTP Board of
Scientific Counselors, August 17, 1984).
Although the NTP has expanded the
breadth of its evaluation of individual
agents and the number of endpoints
critically assessed in the bioassay, the
rodent cancer bioassay study design has
been minimally modified over the past
30 years. For this reason, the program
intends to convene a series of
workshops to evaluate the rodent cancer
bioassay, beginning with choice of
species and strain. Future workshops
will address other study design issues,
such as diet, study length, and age at
exposure. The ultimate goal of any
change to the NTP cancer bioassay is to
improve the identification of
carcinogenic potential (i.e., hazard
identification) and/or improve our
ability to predict cancer in humans.
Request for Comments
Public input at this meeting is invited
and time is set aside for the presentation
of public comments on any agenda
topic. Each organization is allowed one
time slot per agenda topic. At least 7
minutes will be allotted to each speaker,
and if time permits, may be extended to
10 minutes. Registration for oral
comments will also be available on-site,
although time allowed for presentation
by on-site registrants may be less then
that for pre-registered speakers and will
be determined by the number of persons
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
17103
who register at the meeting. Written
statements can supplement and may
expand the oral presentation. If
registering on-site and reading from
written text, please bring 40 copies of
the statement for distribution and to
supplement the record. Written
comments received in response to this
notice will be posted on the NTP Web
site (https://ntp.niehs.nih.gov select
‘‘Meetings and Workshops’’).
Persons submitting written comments
should include their name, affiliation,
mailing address, phone, fax, e-mail, and
sponsoring organization (if any) with
the document. Individuals wishing to
submit historical control data are
encouraged to contact Dr. Angela KingHerbert prior to submission (see FOR
FURTHER INFORMATION CONTACT above).
References
Festing, MF. (1995). Use of a
multistrain assay could improve the
NTP carcinogenesis bioassay. Environ
Health Perspect. 1995 Jan;103(1):44–52.
Available: https://ehp.niehs.nih.gov/.
Meeting Minutes of the NTP Board of
Scientific Counselors (BSC)—June 29,
2004. Available: https://ntpserver.niehs.nih.gov/ntpweb/
index.cfm?objectid=720164F2-BDB7CEBA-F5C6A2E21851F0C4.
Meeting Minutes of the NTP Board of
Scientific Counselors Technical Reports
Review Subcommittee (TRR
Subcommittee)—May 22, 2003.
Available: https://ntpserver.niehs.nih.gov/ntpweb/
index.cfm?objectid=9404F3B3-F1F6–
975E–70F0DB8B0FDF8F86.
Meeting Minutes of the Scientific
Advisory Committee on Alternative
Toxicological Methods (SACATM)—
March 10–11, 2004. Available: https://
ntp-server.niehs.nih.gov/ntpweb/
index.cfm?objectid=AF6CC417-F1F6–
975E–75B5F3FF7DF1CDDC.
Dated: March 22, 2005.
Samuel H. Wilson,
Deputy Director, National Institute of
Environmental Health Sciences.
[FR Doc. 05–6605 Filed 4–1–05; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director; Office of Dietary
Supplements: Notice of Opportunity
for Public Comment and Public
Meeting
Background
The Office Dietary Supplements
(ODS) was established in the Office of
E:\FR\FM\04APN1.SGM
04APN1
17104
Federal Register / Vol. 70, No. 63 / Monday, April 4, 2005 / Notices
the Director, NIH, in 1995 as a major
provision of the Dietary Supplement
Health and Education Act of 1994
(DSHEA). A key early activity was the
development of a Strategic Plan to
define the mission of ODS and to define
program goals. It was prepared with
considerable input from NIH Institutes
and Centers, several Federal agencies,
consumers, and other interested parties.
The original Strategic Plan guided ODS
activities and programs from 1998 to
2003.
In 2003, the Office of Dietary
Supplements undertook a public
process to review its original Strategic
Plan and developed a revised Strategic
Plan for 2004–2009 entitled, ‘‘Promoting
Quality Science in Dietary Supplement
Research, Education, and
Communication’’. This document was
published in January 2004 and is
available by e-mail request to
ods@nih.gov, and on the ODS Web site
at https://ods.od.nih.gov.
The revised ODS Strategic Plan for
2004–2009 reviews the programs and
activities that were initiated under the
original Strategic plan during 1998–
2003 and identified five major program
goals related to research, education and
communication for 2004–2009:
• Expand the evaluation of the role of
dietary supplements in disease
prevention and in reduction of risk
factors associated with disease.
• Foster research that evaluates the
role of dietary supplements in
maintaining and improving optimal
physical and mental health and
performance.
• Stimulate and support research to
further understanding of the
biochemical and cellular effects of
dietary supplements on biological
systems and their physiological impact
across the life cycle.
• Promote and support the
development and improvement of
methodologies appropriate to the
scientific study of dietary supplement
ingredients.
• Expand and conduct outreach
activities that inform and educate the
public, health care providers, and
scientists about the benefits and risks of
dietary supplements.
Since its inception in 1995 under
DSHEA, the original and revised
strategic plans focus on implementation
of the ODS Mission: ‘‘to strengthen
knowledge and understanding of dietary
supplements by evaluating scientific
information, stimulating and supporting
research, disseminating research results,
and educating the public to foster an
enhanced quality of life and health for
the U.S. population.’’
VerDate jul<14>2003
15:19 Apr 01, 2005
Jkt 205001
The ODS will hold an open public
meeting on May 20, 2005 at the location
and time listed below to receive
comments and suggestions on
additional needs and opportunities
related to the 2004–2009 ODS Strategic
Plan. Information about the meeting,
including a link to the registration form
and the tentative agenda, is available on
ODS Web site https://ods.od.nih.gov.
There is no registration fee. The overall
purpose of this public meeting is to
provide interested parties a time to
identify new opportunities and
emerging needs for possible
incorporation in the ODS research,
education, and communication
programs and activities. To address this
purpose, guidance is being requested
from all persons and organizations in
the dietary supplement community.
Materials that describe the current
ODS programs and activities,
information about the public meeting,
and a link to the meeting registration
form are available on the ODS Web site
at https://ods.od.nih.gov. In addition, the
materials are available from the Office at
the address listed below. On or about
April 15, 2005, information and data on
ODS programs and activities will be
updated and will be available on the
ODS Web site and at the address listed
below as well as at the public meeting.
The open meeting will begin with a
brief presentation of the current and
emerging programs and activities of the
ODS. Several invited speakers
representing the broad range of interests
in the dietary supplement user
community will be asked to comment
on emerging needs and opportunities
that can enhance the scope and depth of
ODS programs. There will be an
opportunity for individuals and
organizations to provide their views and
suggestions on possible additional
directions that ODS should consider in
its five year Strategic Plan.
We will use all information received
at the meeting as well as written
comments received by 5 p.m. e.s.t., on
June 30, 2005 in response to this request
in considering modifications to the ODS
Strategic Plan for 2004–2009. Comments
and suggestions should be forwarded to
the address listed below or sent to
ODSplan@od.nih.gov. Results of this
review will be shared with the ODS
Trans-NIH/Agency Working Group, a
Federal interagency group convened by
ODS to enhance cooperation and
communication across Federal
departments, agencies, institutes,
centers, and offices concerning research,
education , and communication about
dietary supplements. In addition, results
of this review will be posted on the ODS
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Web site and will be available upon
request.
Meeting Title: Office of Dietary
Supplements Public Meeting.
Date: May 20, 2005.
Time: 9 a.m.–4 p.m.
Place: Marriott Bethesda North Hotel
and Conference Center, 5701 Marinelli
Road, North Bethesda, MD 20852.
Contact Person: Kenneth D. Fisher,
Ph.D., Office of Dietary Supplements,
6100 Executive Boulevard, Room 3B01,
Bethesda, MD 20892–7517, Phone: (301)
435–2920, Fax: (301) 480–1845, e-mail:
ODSplan@od.nih.gov.
Public Participation
The meeting is open to the public
with attendance limited by the
availability of space on a first come, first
served basis. Interested persons and
organizations that wish to present oral
comments should indicate this when
registering on the ODS Web site or at
https://www.scgcorp.com/odspublicmtg,
no later than May 6, 2005.
Oral comments will be limited to
three minutes; however, submission of
additional documentation is
encouraged. Individuals who register to
speak will be assigned in the order in
which they registered. Due to time
constraints, only one representative
from each organization will be allotted
time for oral presentation. We may limit
the number of speakers and the time
allotted depending on the number of
registrants. All requests to register
should include the name, address,
telephone number, and business or
professional affiliation of the interested
party. If time permits, we will allow any
person attending the meeting who has
not registered to speak in advance of the
meeting to make a brief oral statement
during the time set aside for public
comments and at the chairperson’s
discretion.
We encourage individuals unable to
attend the meeting and all interested
parties to send written comments to the
Office of Dietary Supplements by mail,
fax, or electronically. If possible,
comments that are mailed or faxed
should also be forwarded electronically.
Persons needing special assistance,
such as sign language interpretation or
other special accommodations at the
meeting should indicate this when
registering or contact the Office of
Dietary Supplements at the address or
telephone number listed no later than
April 29, 2005.
E:\FR\FM\04APN1.SGM
04APN1
Federal Register / Vol. 70, No. 63 / Monday, April 4, 2005 / Notices
Dated: March 23, 2005.
Paul M. Coates,
Director, Office of Dietary Supplements,
Office of the Director, National Institutes of
Health.
[FR Doc. 05–6606 Filed 4–1–05; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Federal Emergency
Management Agency, Emergency
Preparedness and Response Directorate,
U.S. Department of Homeland Security.
ACTION: Notice and request for
comments.
AGENCY:
SUMMARY: The Federal Emergency
Management Agency (FEMA) has
submitted the following information
collection to the Office of Management
and Budget (OMB) for review and
clearance in accordance with the
requirements of the Paperwork
Reduction Act of 1995 (44 U.S.C.
Chapter 35). The submission describes
the nature of the information collection,
the categories of respondents, the
estimated burden (i.e., the time, effort
and resources used by respondents to
respond) and cost, and includes the
actual data collection instruments
FEMA will use.
Title: Implementation of Coastal
Barrier Resources Act.
OMB Number: 1660–0010.
Abstract: When an application for
flood insurance is submitted for
buildings located in Coastal Barrier
Resources (CBRS) communities, one of
the following types of documentation
must be submitted as evidence of
eligibility:
—Certification from a community
official stating the building is not
located in a designated CBRS area.
—A legally valid building permit or
certification from a community
official stating that the building’s start
of construction date precede the date
that the community was identified in
the system.
Affected Public: Individuals or
households; Business or other for-profit;
Not-for-profit institutions; Farms;
Federal Government; and State, Local or
Tribal Government.
Number of Respondents: 60.
Estimated Time per Respondent: 1.5
hours.
VerDate jul<14>2003
15:19 Apr 01, 2005
Jkt 205001
Estimated Total Annual Burden
Hours: 90 hours.
Frequency of Response: Once.
Comments: Interested persons are
invited to submit written comments on
the proposed information collection to
the Office of Information and Regulatory
Affairs at OMB, Attention: Desk Officer
for the Department of Homeland
Security/FEMA, Docket Library, Room
10102, 725 17th Street, NW.,
Washington, DC 20503, or facsimile
number (202) 395–7285. Comments
must be submitted on or before 30 days
from the date of this notice is published
in the Federal Register.
FOR FURTHER INFORMATION CONTACT:
Requests for additional information or
copies of the information collection
should be made to Muriel B. Anderson,
Section Chief, Records Management,
FEMA at 500 C Street, SW., Room 316,
Washington, DC 20472, facsimile
number (202) 646–3347, or e-mail
address FEMA-InformationCollections@dhs.gov.
Dated: March 18, 2005.
George S. Trotter,
Acting Branch Chief, Information Resources
Management Branch, Information
Technology Services Division.
[FR Doc. 05–6544 Filed 4–1–05; 8:45 am]
BILLING CODE 9110–11–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[FEMA–1584–DR]
Alaska; Major Disaster and Related
Determinations
Federal Emergency
Management Agency, Emergency
Preparedness and Response Directorate,
Department of Homeland Security.
ACTION: Notice.
AGENCY:
This is a notice of the
Presidential declaration of a major
disaster for the State of Alaska (FEMA–
1584–DR), dated March 14, 2005, and
related determinations.
EFFECTIVE DATE: March 14, 2005.
FOR FURTHER INFORMATION CONTACT:
Magda Ruiz, Recovery Division, Federal
Emergency Management Agency,
Washington, DC 20472, (202) 646–2705.
SUPPLEMENTARY INFORMATION: Notice is
hereby given that, in a letter dated
March 14, 2005, the President declared
a major disaster under the authority of
the Robert T. Stafford Disaster Relief
and Emergency Assistance Act, 42
SUMMARY:
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
17105
U.S.C. 5121–5206 (the Stafford Act), as
follows:
I have determined that the damage in
certain areas of the State of Alaska, resulting
from a severe winter storm on January 7–12,
2005, is of sufficient severity and magnitude
to warrant a major disaster declaration under
the Robert T. Stafford Disaster Relief and
Emergency Assistance Act, 42 U.S.C. 5121–
5206 (the Stafford Act). Therefore, I declare
that such a major disaster exists in the State
of Alaska.
In order to provide Federal assistance, you
are hereby authorized to allocate from funds
available for these purposes such amounts as
you find necessary for Federal disaster
assistance and administrative expenses.
You are authorized to provide Public
Assistance in the designated areas; Hazard
Mitigation throughout the State; and any
other forms of assistance under the Stafford
Act you may deem appropriate. Consistent
with the requirement that Federal assistance
be supplemental, any Federal funds provided
under the Stafford Act for Public Assistance
and Hazard Mitigation will be limited to 75
percent of the total eligible cost. If Other
Needs Assistance under Section 408 of the
Stafford Act is later warranted, Federal
funding under that program will also be
limited to 75 percent of the total eligible
costs.
Further, you are authorized to make
changes to this declaration to the extent
allowable under the Stafford Act.
The Federal Emergency Management
Agency (FEMA) hereby gives notice that
pursuant to the authority vested in the
Under Secretary for Emergency
Preparedness and Response, Department
of Homeland Security, under Executive
Order 12148, as amended, William
Lokey, of FEMA is appointed to act as
the Federal Coordinating Officer for this
declared disaster.
I do hereby determine the following
areas of the State of Alaska to have been
affected adversely by this declared
major disaster:
North Slope Borough for Public Assistance.
All boroughs and Regional Education
Attendance Areas in the State of Alaska are
eligible to apply for assistance under the
Hazard Mitigation Grant Program.
(The following Catalog of Federal Domestic
Assistance Numbers (CFDA) are to be used
for reporting and drawing funds: 97.030,
Community Disaster Loans; 97.031, Cora
Brown Fund Program; 97.032, Crisis
Counseling; 97.033, Disaster Legal Services
Program; 97.034, Disaster Unemployment
Assistance (DUA); 97.046, Fire Management
Assistance; 97.048, Individuals and
Households Housing; 97.049, Individuals and
Households Disaster Housing Operations;
97.050, Individuals and Households
Program—Other Needs; 97.036, Public
E:\FR\FM\04APN1.SGM
04APN1
]]>Agencies
[Federal Register Volume 70, Number 63 (Monday, April 4, 2005)]
[Notices]
[Pages 17103-17105]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-6606]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director; Office of Dietary Supplements: Notice of
Opportunity for Public Comment and Public Meeting
Background
The Office Dietary Supplements (ODS) was established in the Office
of
[[Page 17104]]
the Director, NIH, in 1995 as a major provision of the Dietary
Supplement Health and Education Act of 1994 (DSHEA). A key early
activity was the development of a Strategic Plan to define the mission
of ODS and to define program goals. It was prepared with considerable
input from NIH Institutes and Centers, several Federal agencies,
consumers, and other interested parties. The original Strategic Plan
guided ODS activities and programs from 1998 to 2003.
In 2003, the Office of Dietary Supplements undertook a public
process to review its original Strategic Plan and developed a revised
Strategic Plan for 2004-2009 entitled, ``Promoting Quality Science in
Dietary Supplement Research, Education, and Communication''. This
document was published in January 2004 and is available by e-mail
request to ods@nih.gov, and on the ODS Web site at https://
ods.od.nih.gov.
The revised ODS Strategic Plan for 2004-2009 reviews the programs
and activities that were initiated under the original Strategic plan
during 1998-2003 and identified five major program goals related to
research, education and communication for 2004-2009:
Expand the evaluation of the role of dietary supplements
in disease prevention and in reduction of risk factors associated with
disease.
Foster research that evaluates the role of dietary
supplements in maintaining and improving optimal physical and mental
health and performance.
Stimulate and support research to further understanding of
the biochemical and cellular effects of dietary supplements on
biological systems and their physiological impact across the life
cycle.
Promote and support the development and improvement of
methodologies appropriate to the scientific study of dietary supplement
ingredients.
Expand and conduct outreach activities that inform and
educate the public, health care providers, and scientists about the
benefits and risks of dietary supplements.
Since its inception in 1995 under DSHEA, the original and revised
strategic plans focus on implementation of the ODS Mission: ``to
strengthen knowledge and understanding of dietary supplements by
evaluating scientific information, stimulating and supporting research,
disseminating research results, and educating the public to foster an
enhanced quality of life and health for the U.S. population.''
The ODS will hold an open public meeting on May 20, 2005 at the
location and time listed below to receive comments and suggestions on
additional needs and opportunities related to the 2004-2009 ODS
Strategic Plan. Information about the meeting, including a link to the
registration form and the tentative agenda, is available on ODS Web
site https://ods.od.nih.gov. There is no registration fee. The overall
purpose of this public meeting is to provide interested parties a time
to identify new opportunities and emerging needs for possible
incorporation in the ODS research, education, and communication
programs and activities. To address this purpose, guidance is being
requested from all persons and organizations in the dietary supplement
community.
Materials that describe the current ODS programs and activities,
information about the public meeting, and a link to the meeting
registration form are available on the ODS Web site at https://
ods.od.nih.gov. In addition, the materials are available from the
Office at the address listed below. On or about April 15, 2005,
information and data on ODS programs and activities will be updated and
will be available on the ODS Web site and at the address listed below
as well as at the public meeting.
The open meeting will begin with a brief presentation of the
current and emerging programs and activities of the ODS. Several
invited speakers representing the broad range of interests in the
dietary supplement user community will be asked to comment on emerging
needs and opportunities that can enhance the scope and depth of ODS
programs. There will be an opportunity for individuals and
organizations to provide their views and suggestions on possible
additional directions that ODS should consider in its five year
Strategic Plan.
We will use all information received at the meeting as well as
written comments received by 5 p.m. e.s.t., on June 30, 2005 in
response to this request in considering modifications to the ODS
Strategic Plan for 2004-2009. Comments and suggestions should be
forwarded to the address listed below or sent to ODSplan@od.nih.gov.
Results of this review will be shared with the ODS Trans-NIH/Agency
Working Group, a Federal interagency group convened by ODS to enhance
cooperation and communication across Federal departments, agencies,
institutes, centers, and offices concerning research, education , and
communication about dietary supplements. In addition, results of this
review will be posted on the ODS Web site and will be available upon
request.
Meeting Title: Office of Dietary Supplements Public Meeting.
Date: May 20, 2005.
Time: 9 a.m.-4 p.m.
Place: Marriott Bethesda North Hotel and Conference Center, 5701
Marinelli Road, North Bethesda, MD 20852.
Contact Person: Kenneth D. Fisher, Ph.D., Office of Dietary
Supplements, 6100 Executive Boulevard, Room 3B01, Bethesda, MD 20892-
7517, Phone: (301) 435-2920, Fax: (301) 480-1845, e-mail:
ODSplan@od.nih.gov.
Public Participation
The meeting is open to the public with attendance limited by the
availability of space on a first come, first served basis. Interested
persons and organizations that wish to present oral comments should
indicate this when registering on the ODS Web site or at https://
www.scgcorp.com/odspublicmtg, no later than May 6, 2005.
Oral comments will be limited to three minutes; however, submission
of additional documentation is encouraged. Individuals who register to
speak will be assigned in the order in which they registered. Due to
time constraints, only one representative from each organization will
be allotted time for oral presentation. We may limit the number of
speakers and the time allotted depending on the number of registrants.
All requests to register should include the name, address, telephone
number, and business or professional affiliation of the interested
party. If time permits, we will allow any person attending the meeting
who has not registered to speak in advance of the meeting to make a
brief oral statement during the time set aside for public comments and
at the chairperson's discretion.
We encourage individuals unable to attend the meeting and all
interested parties to send written comments to the Office of Dietary
Supplements by mail, fax, or electronically. If possible, comments that
are mailed or faxed should also be forwarded electronically.
Persons needing special assistance, such as sign language
interpretation or other special accommodations at the meeting should
indicate this when registering or contact the Office of Dietary
Supplements at the address or telephone number listed no later than
April 29, 2005.
[[Page 17105]]
Dated: March 23, 2005.
Paul M. Coates,
Director, Office of Dietary Supplements, Office of the Director,
National Institutes of Health.
[FR Doc. 05-6606 Filed 4-1-05; 8:45 am]
BILLING CODE 4140-01-P
